T G Schwan

Title: T G Schwan: Innovator in Lyme Disease Diagnostics

Introduction

T G Schwan is a notable inventor based in Hamilton, MT (US), recognized for his contributions to the field of medical diagnostics, particularly concerning Lyme disease. With a total of 2 patents, Schwan has made significant strides in developing antigenic proteins that aid in the diagnosis of Lyme borreliosis.

Latest Patents

Schwan's latest patents focus on antigenic proteins specific to Borrelia burgdorferi, the bacterium responsible for Lyme disease. One of his inventions details a 39-kilodalton antigen that is crucial for diagnosing mammals previously or currently infected with Lyme borreliosis. The proteins, particularly the 39 kDa proteins (.alpha. and .beta.), exhibit reactivity with Lyme borreliosis serum and can be utilized in diagnostic applications. Another patent similarly addresses antigenic proteins of Borrelia burgdorferi, emphasizing their molecular weight and diagnostic potential.

Career Highlights

Throughout his career, T G Schwan has worked with various organizations, including the United States of America as represented by the Department of Health. His work has significantly impacted the understanding and diagnosis of Lyme disease, showcasing his commitment to advancing medical science.

Collaborations

Schwan has collaborated with notable individuals in his field, including Warren J Simpson, enhancing the research and development of diagnostic tools for Lyme disease.

Conclusion

T G Schwan's innovative work in the development of antigenic proteins for Lyme disease diagnosis highlights his importance in the medical field. His contributions continue to pave the way for improved diagnostic methods, ultimately benefiting public health.